Response-adapted therapy with infusional EPOCH chemotherapy plus rituximab in HIV-associated, B-cell non-Hodgkin's lymphoma

Authors

Joseph A. Sparano, Montefiore Medical Center
Jeannette Y. Lee, University of Arkansas for Medical Sciences
Lawrence D. Kaplan, University of California, San Francisco
Juan Carlos Ramos, University of Miami
Richard F. Ambinder, Johns Hopkins University
William Wachsman, University of California - San Diego
David Aboulafia, Virginia Mason Cancer Institute, Seattle
Ariela Noy, Weill Cornell Medical College
David H. Henry, Pennsylvania Hospital
Lee Ratner, Washington University School of Medicine in St. Louis
Ethel Cesarman, Weill Cornell Medical College
Amy Chadburn, Weill Cornell Medical College
Ronald Mitsuyasu, University of California, Los Angeles
AIDS Malignancy Consortium

Journal

Haematologica

Publication Date

3-1-2021

Volume

106

Issue

3

First Page

730

Last Page

735

Document Type

Open Access Publication

DOI

10.3324/haematol.2019.243386

Rights and Permissions

Sparano, J. A., Lee, J. Y., Kaplan, L. D., Ramos, J. C., Ambinder, R. F., Wachsman, W., Aboulafia, D., Noy, A., Henry, D. H., Ratner, L., Cesarman, E., Chadburn, A., & Mitsuyasu, R. (2021). Response-adapted therapy with infusional EPOCH chemotherapy plus rituximab in HIV-associated, B-cell non-Hodgkin's lymphoma. Haematologica, 106(3), 730–735. https://doi.org/10.3324/haematol.2019.243386

Recommended Citation

Sparano, Joseph A.; Lee, Jeannette Y.; Kaplan, Lawrence D.; Ramos, Juan Carlos; Ambinder, Richard F.; Wachsman, William; Aboulafia, David; Noy, Ariela; Henry, David H.; Ratner, Lee; Cesarman, Ethel; Chadburn, Amy; Mitsuyasu, Ronald; and AIDS Malignancy Consortium, "Response-adapted therapy with infusional EPOCH chemotherapy plus rituximab in HIV-associated, B-cell non-Hodgkin's lymphoma." Haematologica. 106, 3. 730 - 735. (2021).
https://digitalcommons.wustl.edu/open_access_pubs/10322